The need for high-dimensional single-cell measurements 1 Our lab, in common with many others in the field of cancer research and drug discovery, is 2 highly interested in studying the molecular and cellular heterogeneity in human preclinical (e.g. 3 cell lines) and clinical samples (e.g. tumor sections, blood). This is particularly important for a 4 better understanding of the efficacy of drugs and the molecular origins of drug resistance. To 5 this end, a comprehensive view of intercellular heterogeneity involving measurements at single-6 cell resolution is crucial. Multiplexed imaging is an ideal tool to probe not only high-dimensional 7 single-cell data in heterogeneous samples, but also the encoded spatial information in such 8 samples.
9
Multiplexed imaging, a decade ago 10 Early attempts toward multiplexed single-cell imaging included a "toponome" which used 11 photobleaching fluorophores prior to applying the next round of antibodies. 1 iterative staining and imaging to achieve highly multiplexed images of FFPE tissue sections.
46
However, the method has not been widely used since its inception, due to the requirement for the instrumentation, and compatibility with other fluorescence-based assays. In addition, our CycIF 55 approach can be easily applied to high-content and high-throughput screens at very low cost, so 56 it should be highly useful method for drug discovery and preclinical research. also been analyzed using these tools as published in our original paper and follow-up studies.
74
We are now applying CycIF to blood samples, where the "imaging cytometry" approach not only 75 allows us to obtain multiparametric readings of liquid biopsies, but also enables us to 76 immunoprofile clinical specimens.
77
The future of CycIF and analytic workflows from bench to bedside will permit more rapid drug development and 93 biomarker discovery.
